```html

Quinsy (Peritonsillar Infection) – A Complete Patient Guide

Overview

Quinsy, medically known as a peritonsillar infection or peritonsillar abscess, is a collection of pus that forms in the soft tissues beside the tonsil. It typically develops as a complication of acute tonsillitis when the infection spreads beyond the tonsil capsule.

• Who it affects: Most cases occur in teenagers and young adults (15‑30 years), but anyone with a history of recurrent tonsillitis can develop quinsy.
• Prevalence: In the United States, about 30–45 cases per 100,000 individuals are reported annually, accounting for roughly 2 %–5 % of all tonsillitis episodes [1, 2].
• Why it matters: Because the swelling can obstruct the airway and spread to deeper neck spaces, prompt diagnosis and treatment are essential.

Symptoms

The presentation can vary, but the hallmark is severe unilateral throat pain that worsens over 2‑5 days. Common symptoms include:

• Severe sore throat on one side, often radiating to the ear.
• Difficulty swallowing (odynophagia) and a feeling that the throat is “blocked.”
• Fever – usually 38 °C (100.4 °F) or higher.
• Swollen, tender neck on the affected side, sometimes with palpable lymph nodes.
• Change in voice – a “hot‑potato” or muffled quality because of the swelling.
• Trismus (limited mouth opening) – pain when trying to open the mouth wide.
• Ear pain without ear infection, caused by shared nerve pathways.
• Halitosis (bad breath) from necrotic tissue and pus.
• Drooling or inability to keep saliva in the mouth.
• Visible bulge behind the tonsil; the uvula may be pushed toward the opposite side.

Symptoms often develop rapidly after a bout of strep or viral tonsillitis. If any of the above appear and worsen after a “normal” sore throat, seek medical attention promptly.

Causes and Risk Factors

Primary cause

Quinsy results from the spread of bacterial infection from the tonsillar crypts into the surrounding peritonsillar space. The most common pathogens are:

• Group A Streptococcus (Streptococcus pyogenes) – 30‑40 % of cases.
• Staphylococcus aureus, including MRSA strains – 20‑30 %.
• Mixed aerobic and anaerobic bacteria (Fusobacterium, Peptostreptococcus) – 20‑30 %.

Risk factors

• Recurrent acute tonsillitis – repeated infections increase tissue damage and bacterial spread.
• Age 15‑30 years – immune response and social exposure (schools, colleges) raise risk.
• Smoking or exposure to second‑hand smoke – irritates the mucosa and impairs local immunity.
• Immunocompromised state (HIV, chemotherapy, uncontrolled diabetes).
• Recent antibiotic use that may have suppressed some bacteria but allowed resistant strains to proliferate.
• Poor oral hygiene – higher bacterial load in the oropharynx.

Diagnosis

Diagnosis is primarily clinical, but imaging and laboratory tests help confirm the abscess and rule out other conditions.

Clinical examination

• Inspection of the oropharynx reveals a swollen, pus‑filled peritonsillar bulge and a displaced uvula.
• Palpation of the neck may show a tender, fluctuant mass.
• Assessment of trismus and airway patency.

Laboratory tests

• Complete blood count (CBC): elevated white blood cells (leukocytosis) in most patients.
• Throat culture or rapid antigen detection test (RADT): identifies streptococcal infection.
• Pus culture: obtained when the abscess is drained to tailor antibiotic therapy.

Imaging

• Contrast‑enhanced CT scan of the neck: gold standard for differentiating an abscess from cellulitis and for assessing spread to deeper neck spaces.
• Ultrasound (point‑of‑care): can detect fluid collections and guide needle aspiration when CT is unavailable.

Differential diagnosis

Conditions that can mimic quinsy include peritonsillar cellulitis, epiglottitis, retropharyngeal abscess, and malignancy. Accurate diagnosis avoids unnecessary procedures and ensures appropriate treatment.

Treatment Options

Management aims to eradicate infection, relieve pain, and prevent airway compromise.

1. Medications

• Empiric intravenous (IV) antibiotics while awaiting culture results. Recommended regimens (CDC/IDSA guidance) include:
  • Clindamycin 600 mg IV every 8 h (covers anaerobes and MRSA).
  • Or Ampicillin‑sulbactam 3 g IV every 6 h.
  • If MRSA is suspected, add Vancomycin or Linezolid.
• Oral step‑down therapy after 24‑48 h of clinical improvement: amoxicillin‑clavulanate 875/125 mg PO twice daily for 7‑10 days, or clindamycin 300 mg PO four times daily if penicillin‑allergic.
• Pain control: Acetaminophen 650‑1000 mg PO q6h PRN or Ibuprofen 400‑600 mg PO q6‑8h (if no contraindications).
• Hydration & anti‑emetics as needed.

2. Drainage procedures

Antibiotics alone are insufficient for most abscesses; drainage shortens illness and reduces complications.

• Needle aspiration: Performed under local anesthesia; a thin needle punctures the bulge, withdrawing pus. Often the first step and may relieve symptoms quickly.
• Incision & drainage (I&D): A small scalpel cut in the peritonsillar space allows complete evacuation. Usually done in the emergency department or ENT clinic under sedation.
• Quinsy tonsillectomy (abscess tonsillectomy): Indicated for recurrent quinsy, failure of I&D, or when the patient is already scheduled for tonsil removal. Conducted under general anesthesia.

3. Airway management

Severe swelling can threaten the airway. In such cases:

• Prepare for emergent intubation or surgical airway (cricothyrotomy) in the hospital.
• Hospital admission to an intensive care unit (ICU) may be required.

4. Lifestyle and supportive care

• Warm saline gargles (½ tsp salt in 8 oz water) every 4–6 h.
• Soft, cool foods (yogurt, ice cream, mashed potatoes) to minimize pain while swallowing.
• Adequate fluid intake – aim for 2–3 L/day.
• Rest and avoidance of smoking or alcohol until fully healed.

Living with Quinsy (peritonsillar infection)

During treatment

• Follow‑up appointments: Usually within 48 hours after drainage to assess healing and adjust antibiotics.
• Monitor for fever or worsening pain – could signal an unresolved abscess or new infection.
• Oral hygiene: Gentle brushing, alcohol‑free mouthwash, and avoiding spicy foods.

After recovery

• Assess need for tonsillectomy: Up to 30 % of patients with a first quinsy will have recurrence; elective tonsil removal reduces future risk.
• Immunizations: Keep influenza and COVID‑19 vaccines up to date, as viral upper‑respiratory infections can precipitate bacterial superinfection.
• Stay hydrated and maintain a balanced diet to support immune function.
• Track any lingering symptoms: Persistent throat pain >2 weeks warrants re‑evaluation for chronic infection or malignancy.

Prevention

• Prompt treatment of tonsillitis: Early antibiotics for confirmed streptococcal infection reduce spread.
• Good oral hygiene: Brush twice daily, floss, and use an antibacterial mouth rinse.
• Avoid tobacco smoke and limit alcohol, both of which irritate the oropharynx.
• Stay hydrated to keep mucosal surfaces moist and resistant to bacterial colonization.
• Consider tonsillectomy for individuals with:
  • ≥3 episodes of acute tonsillitis per year for 2 consecutive years, or
  • ≥2 episodes of quinsy.
• Vaccinations: Influenza, COVID‑19, and pneumococcal vaccines reduce overall respiratory infection burden.

Complications

If left untreated or incompletely drained, quinsy can lead to serious sequelae:

• Deep neck space infections (parapharyngeal, retropharyngeal abscess) – may spread to mediastinum.
• Airway obstruction – potentially fatal; requires emergency airway securing.
• Sepsis – systemic infection with fever, tachycardia, hypotension.
• Spread to the internal jugular vein → thrombophlebitis (Lemierre’s syndrome).
• Chronic sinusitis or otitis media due to eustachian tube involvement.
• Scarring of the peritonsillar tissue leading to persistent dysphagia.

Early drainage and appropriate antibiotics dramatically lower the risk of these outcomes [3].

When to Seek Emergency Care

References

1. Mayo Clinic. “Peritonsillar abscess (quinsy).” May 2023. Available at: https://www.mayoclinic.org/diseases-conditions/peritonsillar-abscess
2. Centers for Disease Control and Prevention. “Tonsillitis and Peritonsillar Abscess – Epidemiology.” 2022. https://www.cdc.gov/tonsillitis
3. American Academy of Otolaryngology–Head and Neck Surgery. Clinical Practice Guideline: Peritonsillar Abscess. 2021.
4. NIH National Institute of Allergy and Infectious Diseases. “Group A Streptococcus.” 2022. https://www.niaid.nih.gov
5. World Health Organization. “Antibiotic resistance.” 2023. https://www.who.int

```